Efficacy and Safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves'ophthalmopathy: a systematic review and meta-analysis.
Frontiers in endocrinology（2023）
摘要
http://www.crd.york.ac.uk/prospero, identifier CRD42023398170.
更多查看译文
关键词
monoclonal antibodies, tocilizumab, teprotumumab, rituximab, Graves ophthalmopathy, treatment, meta-analysis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要